Wednesday, April 21, 2021 8:38:04 AM
Relief needs to get their stuff together. There’s another player in town.
https://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-announces-positive-results-phase-1b-study-covi-msctm
https://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-announces-positive-results-phase-1b-study-covi-msctm
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
